Newspaper article Pittsburgh Post-Gazette (Pittsburgh, PA)

12 Companies to Spur Investment Ideas

Newspaper article Pittsburgh Post-Gazette (Pittsburgh, PA)

12 Companies to Spur Investment Ideas

Article excerpt

Never before has there been such great anticipation for my list of 12 companies, whose only goal is to stimulate your research resourcefulness.

Biogen Idec (BIIB) -- Tecfidera, its oral multiple sclerosis drug has already managed to exceed expectations. Current outlook is for 2013 sales to total $830 million, with annual sales exceeding $5 billion by 2019.

Gilead (GILD) -- No drug approved this year has the expectations of Sovaldi, Gilead's treatment for hepatitis C. Although annual sales are not expected to hit their peak until 2018, two weeks of available data has indicated Q4 sales of $98 million, exceeding forecasts of $73 million plus.

AbbVie (ABBV) -- A research-based biopharmaceutical company spun off from Abbott Labs. Its product portfolio includes a range of adult and pediatric pharmaceuticals, including biologic therapy Humira for autoimmune diseases, Synthroid for hypothyroidism, and AndroGel, a testosterone replacement therapy.

Abbott Labs (ABT) -- Engages in the development, manufacture and sale of a large smorgasbord of health care products to retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices and government agencies.

Aflac (AFL) -- Aflac is the country's largest provider of supplemental insurance. The company has a strong balance sheet, good dividend history and solid earnings growth. The payout ratio over the past 10 years has only increased by 15 percent, while the dividend payout has seen a 17 percent compounded annual growth rate, meaning the company is not hiding a lack of dividend growth by increasing the payout ratio.

MWI Veterinary Supply (MWIV) -- Estimates FY 2015 revenues of $2.89 to $2.94 billion, representing a growth rate of 23 to 25 percent. Earnings estimated to come in at $5.47 to $5.67 per share, an increase of 10.5 to 14.5 percent year-over-year.

Intel (INTC) -- The tablet market will be its focus in 2014. A key driver will be Bay Trail, Intel's latest system-on-a-chip processor family-developed for devices that need a delicate balance of performance and power. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed


An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.